Is C. auris airborne?
Understanding the Mycobacterium tuberculosis Respiratory Question
C. auris, also known as the hospital-acquired bacterium, is a significant public health concern. The Centers for Disease Control and Prevention (CDC) has reported an increase in cases of C. auris in healthcare settings worldwide, leading to concerns about its airborne transmission. Understanding the nature of C. auris and its potential for airborne transmission is crucial in developing effective strategies to control outbreaks.
What is C. auris?
C. auris is a bacterium that belongs to the genus Mycobacterium. It is a member of the Mycobacterium tuberculosis species, but is genetically distinct from tuberculosis (TB) and is often classified as a separate species. C. auris was first identified in 2013 in an autopsy specimen from a patient in Japan, and has since been reported in healthcare settings in several countries, including the United States, China, and India.
Pathogenicity and Infection
- C. auris is a pathogenic bacterium that can cause severe infections, including pneumonia, lung abscesses, and disseminated disease.
- The bacterium is typically acquired through inhalation of spores or aerosolized particles, which can be present in respiratory droplets, air particles, or contaminated surfaces.
Airborne Transmission
- While C. auris is not typically transmitted through the air, it can be airborne if inhaled in aerosolized form.
- The risk of airborne transmission is highest when the bacterium is present in a high concentration or when the patient is in close proximity to the source of the aerosolized particles.
Factors Affecting Airborne Transmission
- Temperature: C. auris is more virulent at temperatures between 39°C and 44°C.
- Humidity: Low humidity can facilitate the growth and transmission of C. auris by promoting the formation of aerosolized particles.
- Air circulation: Poor air circulation or lack of ventilation can increase the risk of airborne transmission by allowing the bacterium to be inhaled for longer periods.
Control Measures
- Hand hygiene: C. auris is highly contagious and can spread through respiratory droplets. Hand hygiene is therefore critical in preventing the transmission of the bacterium.
- Gowns and personal protective equipment (PPE): Wearing gloves, masks, and eye protection can reduce the risk of airborne transmission by preventing the spread of spores.
- Surveillance and tracking: Monitoring and tracking the number of C. auris cases and transmission events can help identify clusters and inform targeted control measures.
Vaccination
- C. auris vaccine development: Researchers are actively exploring the development of a vaccine against C. auris.
- Vaccine efficacy: The efficacy of C. auris vaccines is still being evaluated in clinical trials.
Conclusion
- Understanding the biology and transmission of C. auris is essential in developing effective control measures to prevent the spread of the bacterium in healthcare settings.
- Combination of hand hygiene, gowning, PPE, surveillance, and vaccination may be effective in controlling C. auris outbreaks.